Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02924363 · ClinicalTrials.gov registry record
Effect of MitraClip on Acute and Chronic Reverse Cardiac Remodeling Assessed by CMR: The MITRA-REVERSE Study
A clinical trial, sponsored by Dipan Shah.
- Completed
- Registry status
- 54
- Enrollment target
NCT02924363: Completed study, sponsored by Dipan Shah.
NCT02924363 is a clinical trial that has completed, run by Dipan Shah. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02924363 has completed, sponsored by Dipan Shah.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to use cardiac magnetic resonance (CMR) and echocardiography to define the anatomic and functional remodeling that results from MitraClip implantation. A total of sixty (60) patients undergoing MitraClip implantation will be enrolled across multiple sites. The severity of mitral regurgitation, cardiac morphology and function will be assessed in these patients by taking cardiac magnetic resonance imaging with an FDA approved contrast agent at BASELINE (within 30 days prior to MitraClip implantation), during the ACUTE REMODELING PHASE (pre-discharge following implantation), and during the CHRONIC REMODELING PHASE (6 months post-implantation).
Interventions
- DIAGNOSTIC_TEST Blood sample
- DIAGNOSTIC_TEST Cardiac MRI with or without contrast dye
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-01 |
| Est. Completion | 2021-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02924363
The ClinicalTrials.gov registry entry for NCT02924363 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dipan Shah, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood sample is the first listed.
NCT02924363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02924363 about?
NCT02924363 is a clinical study titled "Effect of MitraClip on Acute and Chronic Reverse Cardiac Remodeling Assessed by CMR: The MITRA-REVERSE Study". The purpose of this study is to use cardiac magnetic resonance (CMR) and echocardiography to define the anatomic and functional remodeling that results from MitraClip implantation. A total of sixty (60) patients undergoing MitraClip implantation will be enrolled across multiple sites. The severity o...
What is the current status of trial NCT02924363?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2017-01. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02924363?
The interventions under investigation include: Blood sample (DIAGNOSTIC_TEST), Cardiac MRI with or without contrast dye (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02924363?
This trial is sponsored by Dipan Shah, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.